UA109736C2 - Поліморфна форма мезилатної солі 2-(2,4,5-заміщеного аніліно)піримідину (варіанти) - Google Patents
Поліморфна форма мезилатної солі 2-(2,4,5-заміщеного аніліно)піримідину (варіанти)Info
- Publication number
- UA109736C2 UA109736C2 UAA201403622A UAA201403622A UA109736C2 UA 109736 C2 UA109736 C2 UA 109736C2 UA A201403622 A UAA201403622 A UA A201403622A UA A201403622 A UAA201403622 A UA A201403622A UA 109736 C2 UA109736 C2 UA 109736C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compounds
- salts
- mutant
- pyrimidine
- substituted anilino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161512061P | 2011-07-27 | 2011-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA109736C2 true UA109736C2 (uk) | 2015-09-25 |
Family
ID=53675818
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201403622A UA109736C2 (uk) | 2011-07-27 | 2012-07-25 | Поліморфна форма мезилатної солі 2-(2,4,5-заміщеного аніліно)піримідину (варіанти) |
| UAA201403623A UA108954C2 (xx) | 2011-07-27 | 2012-07-25 | Сполуки 2-(2,4,5-заміщеного аніліно)піримідину |
| UAA201312949A UA106710C2 (uk) | 2011-07-27 | 2012-07-25 | Сполука 2-(2,4,5-заміщеного аніліно)піримідину та її застосування для лікування раку |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201403623A UA108954C2 (xx) | 2011-07-27 | 2012-07-25 | Сполуки 2-(2,4,5-заміщеного аніліно)піримідину |
| UAA201312949A UA106710C2 (uk) | 2011-07-27 | 2012-07-25 | Сполука 2-(2,4,5-заміщеного аніліно)піримідину та її застосування для лікування раку |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR115019A2 (ru) |
| UA (3) | UA109736C2 (ru) |
-
2012
- 2012-07-25 UA UAA201403622A patent/UA109736C2/ru unknown
- 2012-07-25 UA UAA201403623A patent/UA108954C2/ru unknown
- 2012-07-25 UA UAA201312949A patent/UA106710C2/uk unknown
-
2019
- 2019-03-26 AR ARP190100759A patent/AR115019A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA106710C2 (uk) | 2014-09-25 |
| AR115019A2 (es) | 2020-11-18 |
| UA108954C2 (xx) | 2015-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501326A1 (en) | 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer | |
| EA201590345A1 (ru) | Способы лечения рака с использованием 3-(4-((4-(морфолинометил)бензил)окси)-1-оксоизоиндолин-2-ил)пиперидин-2,6-диона | |
| EA201590624A1 (ru) | Циклические эфиры пиразол-4-ил-гетероциклил-карбоксамидных соединений и способы их применения | |
| TN2015000368A1 (en) | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | |
| MX2013008431A (es) | Antagonista del receptor de mineralocorticoides. | |
| EA201500298A1 (ru) | Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы | |
| EA201290957A1 (ru) | Пиразол-4-илгетероциклилкарбоксамидные соединения и способы их применения | |
| EA201391319A1 (ru) | Способ лечения рака с использованием 3-(5-амино-2-метил-4-оксо-4h-хиназолин-3-ил)пиперидин-2,6-диона | |
| EA201291220A1 (ru) | Производные аминопиримидина в качестве модуляторов lrrk2 | |
| MX2014000536A (es) | Compuestos de 4-piperidinilo para usarse como inhibidores de tanquirasa. | |
| EA201370166A1 (ru) | Содержащие диарилацетиленгидразид ингибиторы тирозинкиназы | |
| UA104489C2 (ru) | Соединения для лечения дислипидемии и родственных болезней | |
| EA201300250A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| MX2012013206A (es) | Inhibidores de quinasa biciclica fusionada. | |
| MX353209B (es) | Antagonistas d2, metodos de sintesis y metodos de uso. | |
| NZ706591A (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| PH12020550228A1 (en) | Epidermal growth factor receptor inhibitors | |
| PH12014501943A1 (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
| EA201300389A1 (ru) | Оксадиазольные ингибиторы продуцирования лейкотриена | |
| UA109736C2 (uk) | Поліморфна форма мезилатної солі 2-(2,4,5-заміщеного аніліно)піримідину (варіанти) | |
| EA202092034A2 (ru) | Производные 2-(2,4,5-замещенного анилино)пиримидина в качестве модуляторов egfr, полезных для лечения рака | |
| NZ621471A (en) | Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | |
| UY33283A (es) | Derivados de 2,3-dihidro-1h-inden-1-il-2,7-diazaspiro[3.5]nonano |